School of Clinical and Basic Medical Sciences, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.
Department of Radiation Oncology, The First Affiliated Hospital of Shandong Second Medical University, Weifang, China.
Front Immunol. 2024 May 3;15:1365554. doi: 10.3389/fimmu.2024.1365554. eCollection 2024.
Accumulating studies have indicated that the gut microbiota plays a pivotal role in the onset of autoimmune diseases by engaging in complex interactions with the host. This review aims to provide a comprehensive overview of the existing literatures concerning the relationship between the gut microbiota and autoimmune diseases, shedding light on the complex interplay between the gut microbiota, the host and the immune system. Furthermore, we aim to summarize the impacts and potential mechanisms that underlie the interactions between the gut microbiota and the host in autoimmune diseases, primarily focusing on systemic lupus erythematosus, rheumatoid arthritis, Sjögren's syndrome, type 1 diabetes mellitus, ulcerative colitis and psoriasis. The present review will emphasize the clinical significance and potential applications of interventions based on the gut microbiota as innovative adjunctive therapies for autoimmune diseases.
越来越多的研究表明,肠道微生物群通过与宿主的复杂相互作用,在自身免疫性疾病的发生中起着关键作用。本综述旨在全面概述有关肠道微生物群与自身免疫性疾病之间关系的现有文献,阐明肠道微生物群、宿主和免疫系统之间的复杂相互作用。此外,我们旨在总结肠道微生物群与宿主在自身免疫性疾病中的相互作用的影响和潜在机制,主要集中在系统性红斑狼疮、类风湿关节炎、干燥综合征、1 型糖尿病、溃疡性结肠炎和银屑病上。本综述将强调基于肠道微生物群的干预措施的临床意义和潜在应用,作为自身免疫性疾病的创新辅助疗法。